The financing round drew participation from Legal & General, Tencent, and QVentures to support genomics software development.
"We are thrilled to be supporting Congenica in developing their world-leading technology to deliver life-changing answers. At QVentures, we strive to support cutting-edge technology companies that really change how an industry operates and we believe David and his team are doing just that. We are pleased that QVentures’ Family Offices and UHNWI investors could join us on that journey."
Graham McDonald led the investor consortium, with funds directed towards team expansion and technological enhancements.
"With existing users in 89 countries and growing, our long-term aim is to become one of the leading global healthcare education providers and to form a worldwide network that can be used to address global healthcare challenges. This investment represents a major step forward in fulfilling our ambitions."
